News
Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...
NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
THURSDAY, April 10, 2025 (HealthDay News) -- Bausch + Lomb has announced a voluntary recall of intraocular lenses on its ...
StockStory.org on MSN6d
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty SegmentLooking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...
NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...
Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...
Learn more about whether Bausch + Lomb Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...
Bausch+Lomb’s Biotrue multi-purpose lens care solution secured a top three ranking in the contact lens category for the ...
Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / ...
Recall issued in response to reports of toxic anterior segment syndrome. HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results